Trials / Recruiting
RecruitingNCT06802731
LivQ-box® Parameters in the Diagnosis of Liver Inflammation
A Multicenter Study on the Application of LivQ-box® Parameters in the Diagnosis of Liver Inflammation in Patients with Non-alcoholic Fatty Liver Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 365 (estimated)
- Sponsor
- Wuxi Hisky Medical Technology Co Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
Detailed description
This study is a multi-center study that retrospectively analyzed and prospectively included 240 NAFLD patients in total who met the inclusion criteria. The laboratory, iLivTouch, and liver biopsy results were collected to evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels. In the end, cut-off values for different stages of inflammation were obtained.
Conditions
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-03-31
- Completion
- 2025-06-30
- First posted
- 2025-01-31
- Last updated
- 2025-01-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06802731. Inclusion in this directory is not an endorsement.